In a recent webcast, Dr. Ronald Korn, Founder and CMO at Imaging Endpoints and Kelie Williams Luby, VP Clinical Trials Software at Mint Medical, presented an integrated, comprehensive analysis using the mint Lesion™ platform for a seamless evaluation of COVID-19 patients and trials.
Together they highlighted the need for expert image analysis and the urgent need for organized data collection, encompassing the multi-dimensional data of imaging, laboratory, clinical, and demographics for COVID-19.
While imaging should not be used as a screening tool for unselected populations, it supports a comprehensive approach which can be applied in both clinical care and clinical trials. The mint Lesion™ platform integrates this multi-dimensional data creating a digital signature for the patient while enabling data quality, integrity, and traceability acquired in a high-trust environment.
-
65 minute(s)
Radiologic Analysis of COVID-19 Infection
Related Resources
Related Resources
Mint in 30 Minutes - How to adopt radiomics research, clinical trial management, and cognitive assistance in clinical routine
During this year’s virtual ECR 2020, we provided an insight into data-driven radiology with our Mint in 30 Minutes webcast. Using live software…
Clinical trial excellence for routine covid-19 assessment
Mint Medical is on the front lines in the fight against COVID-19, proving that radiology can act as a role model for gathering evidence by utilizing…
ExploreCOVID: An explorative cohort study to identify optimal CT imaging biomarkers in combination with clinical markers and PCR-RT for the diagnosis and therapy response assessment of COVID-19
Funded by the German Federal Ministry of Education and Research, the ExploreCOVID project aims to analyze patient history and clinical as well as…